Many of the world's most essential medicines and public health devices are wholly or partly developed in academic laboratories. Their accessibility to those living in poor nations is profoundly affected by the research, licensing and patenting decisions made by universities. This campaign aims to change the licensing and patenting policies at Johns Hopkins University to promote access to JHU inventions by people in developing nations.

It is a stated mission of Johns Hopkins University "to bring the benefits of discovery to the world." As members of the Johns Hopkins University community, we believe we have an opportunity and a responsibility to improve global access to public health goods developed at our institution.

Members of the Johns Hopkins Universities Allied for Essential Medicines (UAEM) chapter founded the Drug Problem campaign to raise awareness within the JHMI community and spark the change we need.

More information about the proposed Global Access Licensing Framework can be found here.

In an appearance on a local radio program in October, 2010, Johns Hopkins' President Daniels spoke about our institutional commitment to global health. Yet Hopkins trails our peer institutions in adopting policies that would advance global health. The Hopkins UAEM team has responded to President Daniels' on-air comments. Read that letter here.

Sign the petition and join the growing list of Hopkins students, faculty and employees who believe that our institution needs a global access licensing policy.

        There are 430 confirmed signatories to the UAEM Hopkins Petition.